Company Overview
IMMUNITYBIO, INC.
IBRXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
113M
2025 FY
Net Income
-351M
2025 FY
Shares Outstanding
920M
2025 FY
EPS
-0.38USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1326110
Exchange
Nasdaq
Location
US